Cliff Asness's MEDP Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 1.35 M shares of Medpace Holdings, Inc. (MEDP) worth $758.06 M, representing 0.40% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 32 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in MEDP, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 404,226 shares. Largest reduction occurred in Q3 2019, reducing 208,207 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Medpace Holdings (MEDP) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medpace Holdings (MEDP) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +324,293 | Add 31.63% | 1.35 M | $561.65 |
| Q3 2025 | +404,226 | Add 65.07% | 1.03 M | $505.33 |
| Q2 2025 | +81,637 | Add 15.13% | 621,184 | $311.13 |
| Q1 2025 | +59,361 | Add 12.36% | 539,547 | $293.71 |
| Q4 2024 | +114,436 | Add 31.29% | 480,186 | $332.23 |
| Q3 2024 | +55,100 | Add 17.74% | 365,750 | $330.26 |
| Q2 2024 | +119,257 | Add 62.31% | 310,650 | $411.85 |
| Q1 2024 | -4,004 | Reduce 2.05% | 191,393 | $402.37 |
| Q4 2023 | +12,087 | Add 6.59% | 195,397 | $306.53 |
| Q3 2023 | +65,614 | Add 55.75% | 183,310 | $242.13 |
| Q2 2023 | +10,783 | Add 10.09% | 117,696 | $236.59 |
| Q1 2023 | +71,655 | Add 203.23% | 106,913 | $184.12 |
| Q4 2022 | -65,977 | Reduce 65.17% | 35,258 | $211.13 |
| Q3 2022 | -93,418 | Reduce 47.99% | 101,235 | $157.17 |
| Q2 2022 | -20,003 | Reduce 9.32% | 194,653 | $148.15 |
| Q1 2022 | +101,466 | Add 89.64% | 214,656 | $163.59 |
| Q4 2021 | -12,600 | Reduce 10.02% | 113,190 | $217.64 |
| Q3 2021 | +19,999 | Add 18.90% | 125,790 | $189.28 |
| Q2 2021 | -14,201 | Reduce 11.83% | 105,791 | $176.31 |
| Q1 2021 | +29,311 | Add 32.32% | 119,992 | $163.87 |
| Q4 2020 | +36,279 | Add 66.69% | 90,681 | $136.02 |
| Q3 2020 | -47,568 | Reduce 46.65% | 54,402 | $111.74 |
| Q2 2020 | -39,639 | Reduce 27.99% | 101,970 | $93.02 |
| Q1 2020 | +2,671 | Add 1.92% | 141,609 | $73.38 |
| Q4 2019 | -71,203 | Reduce 33.88% | 138,938 | $84.06 |
| Q3 2019 | -208,207 | Reduce 49.77% | 210,141 | $84.04 |
| Q2 2019 | -8,888 | Reduce 2.08% | 418,348 | $65.42 |
| Q1 2019 | -17,781 | Reduce 4.00% | 427,236 | $58.97 |
| Q4 2018 | +278,000 | Add 166.45% | 445,017 | $52.93 |
| Q3 2018 | +128,217 | Add 330.46% | 167,017 | $59.91 |
| Q2 2018 | +94 | Add 0.24% | 38,800 | $42.99 |
| Q1 2018 | +38,706 | New Buy | 38,706 | $34.93 |
Cliff Asness's Medpace Holdings Investment FAQs
Cliff Asness first purchased Medpace Holdings, Inc. (MEDP) in Q1 2018, acquiring 38,706 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Medpace Holdings, Inc. (MEDP) for 32 quarters since Q1 2018.
Cliff Asness's largest addition to Medpace Holdings, Inc. (MEDP) was in Q3 2025, adding 1,025,410 shares worth $518.17 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 1,349,703 shares of Medpace Holdings, Inc. (MEDP), valued at approximately $758.06 M.
As of the Q4 2025 filing, Medpace Holdings, Inc. (MEDP) represents approximately 0.40% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Medpace Holdings, Inc. (MEDP) was 1,349,703 shares, as reported at the end of Q4 2025.